Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug/Agent Toxicity by Tissue/Organ”

119 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 119 results

Testing effectiveness (Phase 2)UnknownNCT04138381
What this trial is testing

Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST)

Who this might be right for
Maximum Tolerated DoseGISTMetastatic Adult Soft Tissue Sarcoma+2 more
Grupo Espanol de Investigacion en Sarcomas 30
Not applicableStudy completedNCT05358132
What this trial is testing

ARM-ED: Advanced Respiratory Monitoring Events in Drug Toxicity

Who this might be right for
Respiratory InsufficiencyOverdose of OpiateSedative Overdose+1 more
NHS Greater Glasgow and Clyde 78
Not applicableUnknownNCT03469063
What this trial is testing

Impact of AferBio® on Quality of Life and Chemotherapy Toxicity in Lung Cancer Patients

Who this might be right for
Quality of LifeInfectionDrug Toxicity
Barretos Cancer Hospital 104
Testing effectiveness (Phase 2)Ended earlyNCT00074165
What this trial is testing

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

Who this might be right for
Brain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/OrganLymphoma+1 more
OHSU Knight Cancer Institute 17
Testing effectiveness (Phase 2)Study completedNCT00003068
What this trial is testing

High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/Organ
University of Arizona 30
Large-scale testing (Phase 3)Study completedNCT00245050
What this trial is testing

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganEndometrial Cancer+3 more
Case Comprehensive Cancer Center 34
Not applicableStudy completedNCT01038284
What this trial is testing

Multidisciplinary Collaboration Care in Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Hypertension, Pulmonary
University Hospital, Grenoble 101
Not applicableStudy completedNCT00166608
What this trial is testing

Cytokines Polymorphisms and Acetaminophen Toxicity

Who this might be right for
Drug Toxicity
Arkansas Children's Hospital Research Institute 111
Testing effectiveness (Phase 2)Study completedNCT00003089
What this trial is testing

Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Large-scale testing (Phase 3)Study completedNCT00017004
What this trial is testing

Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia

Who this might be right for
AnemiaCervical AdenocarcinomaCervical Adenosquamous Carcinoma+6 more
Gynecologic Oncology Group 114
Early research (Phase 1)Study completedNCT06214468
What this trial is testing

Protective Effect of Nicotinamide Riboside Against Acetaminophen Toxicity

Who this might be right for
Drug Toxicity
University of South Alabama 26
Large-scale testing (Phase 3)UnknownNCT03885388
What this trial is testing

Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma （GTN） Patients With Score of 5-6

Who this might be right for
Gestational Trophoblastic TumorEffects of ChemotherapyDrug Toxicity
Women's Hospital School Of Medicine Zhejiang University 300
Early research (Phase 1)WithdrawnNCT03077477
What this trial is testing

Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers

Who this might be right for
NeoplasmsMedication ToxicityTolerance
Aminex Therapeutics, Inc.
Not applicableNot Yet RecruitingNCT07008027
What this trial is testing

Real World Asparaginase Therapy Toxicity

Who this might be right for
Drug Toxicity
St. Jude Children's Research Hospital 200
Testing effectiveness (Phase 2)Study completedNCT00006105
What this trial is testing

Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer

Who this might be right for
Bladder CancerDrug/Agent Toxicity by Tissue/Organ
University of Chicago 37
Testing effectiveness (Phase 2)UnknownNCT00003251
What this trial is testing

Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganHead and Neck CancerRadiation Toxicity
University of Illinois at Chicago 46
Post-approval studies (Phase 4)WithdrawnNCT01374061
What this trial is testing

Pre Hospital Evaluation of Video Laryngoscopy

Who this might be right for
Cardiac ArrestRespiratory Distress SyndromeShock+3 more
Assistance Publique - Hôpitaux de Paris
Early research (Phase 1)Study completedNCT00005796
What this trial is testing

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ
Indiana University 10
Not applicableLooking for participantsNCT05512169
What this trial is testing

Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia

Who this might be right for
ALL, ChildhoodPediatric CancerToxicity, Drug+5 more
University of Geneva, Switzerland 556
Not applicableUnknownNCT04657562
What this trial is testing

The New LC-MS/MS Method for Determination of Unbound Tacrolimus in Plasma

Who this might be right for
ImmunosuppressionKidney Transplant RejectionKidney Transplant; Complications+4 more
National Science Centre, Poland 380
Load More Results